Biopsy Testing Suppliers Serving Africa
-
Service providerbased in Palo Alto, CALIFORNIA (USA)
Lucence is a precision oncology company committed to bringing clarity to cancer care. Lucence makes ultrasensitive non-invasive liquid biopsy tests to provide doctors and their patients life-changing information to enable earlier detection and ...
-
Manufacturerbased in Berlin, GERMANY
We revolutionize the way of cancer diagnostics using our unique, proprietary DNA methylation biomarker technology. Epigenomics develops and commercializes patient-friendly, blood-based diagnostic tests across multiple cancer indications with high ...
Epi - Model proColon - Liquid Biopsy Test for The Detection of Colorectal Cancer
The test is available in the United States, Europe, China and selected other countries. ...
CONTACT SUPPLIER -
Manufacturerbased in Seoul, SOUTH KOREA
We detect and analyze genomic profile of tumor DNA with a single draw of blood. With this comprehensive profile, we provide personalized and optimized analysis information that can be utilized in therapy selection and monitoring. Ultimately, we ...
AlphaLiquid - Model Detect - Tumor-Informed, Hybrid-Capture NGS-Based Liquid Biopsy Test
AlphaLiquid® Detect is an industry-first tumor-informed, hybrid-capture NGS-based liquid biopsy test designed for MRD detection and recurrence monitoring in stage I-III solid tumor patients. The assay ...
CONTACT SUPPLIER -
Manufacturerbased in San Diego, CALIFORNIA (USA)
We are dedicated to one thing: improving outcomes for cancer patients. That’s why we focus on developing innovative diagnostic solutions that give patients and doctors the information they need—all from a simple blood test, known as a liquid biopsy. ...
Biocept - Model NGS - Next-Gen Sequencing Breast Panel - Liquid Biopsy Biomarker
Combining Biocept’s Liquid Biopsy biomarker testing expertise with Oncomine™ from Thermo Fisher Scientific’s next-generation sequencing and decision support ...
CONTACT SUPPLIER -
Manufacturerbased in Notting Hill, AUSTRALIA
INOVIQ Ltd (ASX:IIQ) (INOVIQ) is developing and commercialising an innovative portfolio of diagnostic and exosome-based solutions for the earlier detection, diagnosis, prognosis and monitoring of cancer and other diseases to improve patient outcomes ...
-
Manufacturerbased in Pleasanton, CALIFORNIA (USA)
Anchor Molecular is a life science diagnostics company specializing in the development of best-in-class quality controls, reference materials, and reagents for liquid biopsy assays. We focus on liquid biopsy cancer diagnostic test based on cell-free ...
-
Manufacturerbased in New York, NEW YORK (USA)
miR Scientific, LLC is a healthcare company committed to transforming global cancer management by providing early and highly accurate detection, characterization, and monitoring of disease. The Company has developed the miR Disease Management ...
miR Scientific - Disease Management Platform
The company’s proprietary miR Disease Management Platform® was developed to revolutionize the standard of value-based care for cancers and initially focuses on urological cancers. The initial test delivered by the miR ...
CONTACT SUPPLIER -
Manufacturerbased in Gosselies, BELGIUM
We are a genomic and theranostic company specializing in precision medicine for the treatment of patients with cancer and genetic diseases. OncoDNA is a company specializing in precision for the treatment of cancer and other genetic diseases. We are ...
OncoSELECT - Cancer-Specific Biomarker Test Kit on a Liquid Biopsy
OncoSELECT: Smart liquid biopsy panels with selected key genes per tumor type. The Liquid Biopsy Solution For Disease Monitoring Or Therapeutic Decision. OncoSELECT is a fast and minimally invasive analysis of ...
CONTACT SUPPLIER -
Manufacturerbased in Sykesville, MARYLAND (USA)
OTraces, Inc. has built, and extensively filed patents protection on, an early tumor detection and cancer screening software technology. Technology uses well-known math- and physics-based A-I methods including those used in advanced satellite ...
-
Manufacturerbased in Redwood City, CALIFORNIA (USA)
Guardant Health is a leading precision oncology company dedicated to helping conquer cancer through our proprietary blood tests, vast data sets, and advanced analytics. We’re developing blood tests for early detection in high-risk populations and ...
Model Guardant Reveal - Residual Disease Detection And Recurrence Monitoring
Our Guardant Reveal™ test is the first blood-only test that detects residual and recurrent disease in two weeks, without the need for a tissue biopsy. The test detects ...
CONTACT SUPPLIER -
Manufacturerbased in Munich, GERMANY
ImevaX is a Biotech company based in Munich with a focus on facilitating H. pylori Diagnostics with a novel Rapid Diagnostic ...
-
Manufacturerbased in Valladolid, SPAIN
Founded in 2010, AMADIX is a leading molecular diagnostics company, focused on liquid biopsy, developing innovative diagnostic tests for early cancer detection in blood. Our mission is to extend people’s lives by developing disruptive technologies ...
PreveCol - Blood Based Test Cutting Edge Liquid Biopsy Technology
PreveCol, an innovative blood-based test for early colorectal cancer detection. PreveCol is an innovative test based on an algorithm that combines the clinical characteristics identified by Artificial Intelligence ...
CONTACT SUPPLIER -
Manufacturerbased in Syracuse, NEW YORK (USA)
Mesothelioma is an aggressive cancer that affects the lining of the lungs, heart, or abdomen. Caused by the inhalation of asbestos fibers, mesothelioma is often diagnosed in older individuals who worked with asbestos products. Prognosis for ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you